ADVAIR DISKUS ADVAIR - GlaxoSmithKline
ADVAIR DISKUS ADVAIR - GlaxoSmithKline
ADVAIR DISKUS ADVAIR - GlaxoSmithKline
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Table 4<br />
Overall adverse experiences with ≥ 3% incidence in controlled<br />
clinical trials with <strong>ADVAIR</strong> ® <strong>DISKUS</strong> ® in patients with COPD<br />
Adverse Event<br />
<strong>ADVAIR</strong> ®<br />
<strong>DISKUS</strong> ®<br />
50/500 mcg<br />
(n = 169)<br />
%<br />
<strong>ADVAIR</strong> ®<br />
<strong>DISKUS</strong> ®<br />
50/250 mcg<br />
(n = 178)<br />
%<br />
Fluticasone<br />
propionate<br />
500 mcg<br />
(n = 391)<br />
%<br />
Fluticasone<br />
propionate<br />
250 mcg<br />
(n = 399)<br />
%<br />
Salmeterol<br />
50 mcg<br />
(n = 341)<br />
%<br />
Placebo<br />
(n = 576)<br />
%<br />
Any event 78 70 80 74 68 69<br />
Infections and Infestations<br />
Upper respiratory tract<br />
infection<br />
17 12 18 16 11 15<br />
Sinusitis 3 3 3 6 4 2<br />
Sinusitis/sinus infection 4 2 2 2 1 2<br />
Candidiasis mouth/throat 7 10 12 6 2